Tel.:
+34 91 736 2385
LOCAL TIME
Contact:
Katarina Gluic
Hours:
Mon-Thu 8:30-17:00 Fri 8:30-15:00
07:03
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
ESMO 17th World Congress on Gastrointestinal Cancer 2015
1 - 4 July 2015 Barcelona
About us
FAQs
Help Line
Personal Area
Homepage
Discussion forum -
ESMO 17th World Congress on Gastrointestinal Cancer 2015
Topic -
Clinical Gastric Cancer
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
Thread / Poster
Author
Replies
Last reply
Exploratory analysis of tumor growth rate in patients with advanced gastrointestinal stromal tumors (GIST) treated with regorafenib in the GRID phase 3 trial
Christian Kappeler
1
7/2/2015 1:49:00 PM
Trastuzumab induced cardiotoxicity in Her2 positive metastatic oeso-gastric cancers
Jerome MARTIN-BABAU
1
7/2/2015 11:59:00 AM
Serum tumor markers as predictors of overall response rate and clinical benefit in patients with advanced esophagogastric adenocarcinoma (EGA) treated with chemotherapy
Silvia Patricia Cortez
1
6/30/2015 10:39:00 PM
Impact of disease biology and stage on outcomes for oesophageal and gastric adenocarcinoma (OGA) treated with neoadjuvant chemotherapy.
Elisa Fontana
1
6/30/2015 10:52:00 AM
STAGING ECHOENDOSCOPY IN ESOPHAGOGASTRIC CANCER PATIENTS ONGOING SURGERY
ANA VILLAESCUSA MOLINA
1
6/29/2015 6:21:00 PM
Intestinal versus Diffuse Gastric Cancer Chemoradiation for all or do we need different therapeutic approaches?
Ana Rita Garcia
1
6/23/2015 3:31:00 PM
Can high levels of preoperative carbohydrate antigen 19-9 be a predictor of survival in gastric cancer?
Ana Rita Garcia
1
6/23/2015 3:25:00 PM
Evaluation of prognostic and predictive factors in second-line treatment with irinotecan based chemotherapy in gastric cancer.
Renata Biernacka
1
6/22/2015 10:11:00 PM
TREATMENT OF METASTATIC GASTRIC CANCER WITH DOCETAXEL-IRINOTECAN COMBINATION. VIRGEN DE LAS NIEVES UNIVERSITY HOSPITAL EXPERIENCE.
LUCIA OCHOA VALLEJO
1
6/22/2015 6:12:00 PM
High BIM mRNA levels associated with longer survival in advanced gastric cancer
Nandie Wu
1
6/22/2015 4:15:00 PM
Evaluation of driver mutations involving in RAS-RAF/PI3K-mToR pathway in gastric signet ring cell carcinoma
Baorui Liu
1
6/22/2015 3:57:00 PM
MET Overexpression and Amplification Define a Distinct Molecular Subgroup for Targeted Therapies in Gastric Cancer
Jia Wei
1
6/22/2015 3:47:00 PM
FDG PET/CT AS A PREOPERATIVE STAGING MODALITY FOR EARLY GASTRIC CANCER.
Hyungwoo Oh
1
6/22/2015 11:52:00 AM
SMALL CELL STOMACH MALT-LYMPHOMA
Makhsud Mallaev
1
6/20/2015 1:41:00 PM
TRIGGER FACTOR IN STOMACH MALT-LYMPHOMA
Makhsud Mallaev
1
6/20/2015 1:30:00 PM
Results of surgical therapy for loco-regional recurrence of gastric cancer
Anna Chayka
1
6/16/2015 10:49:00 AM
Most viewed poster for this congress
Poster:
98
Visits:
485
Title:
LOCAL ADVANCED GASTRIC CANCER: OPTIMIZATION OF MANAGEMENT
Authors:
Oleg Kshivets ,
Centre:
surgery department, Kaluga Cancer Center
Poster most viewed in this topic
Poster:
98
Visits:
485
Title:
LOCAL ADVANCED GASTRIC CANCER: OPTIMIZATION OF MANAGEMENT
Authors:
Oleg Kshivets ,
Centre:
surgery department, Kaluga Cancer Center
About us
Terms and Conditions
Special Access
Commercial Web Access
Follow us on: